Primary Site >> Biliary tract Cancer
Gene >> NFE2L2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. PMID: 18692501 |
Ref: Redox modulation and human bile duct cancer inhibition by curcumin. PMID: 20510329 Ref: Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters. PMID: 20626588 Ref: Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. PMID: 20828733 Ref: Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells. PMID: 20938215 |
Ref: Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. PMID: 21577322 |
Ref: Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. PMID: 22213475 Ref: Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. PMID: 22901367 |
Ref: Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients. PMID: 24528044 |
Ref: Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells. PMID: 25708948 |
Ref: Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. PMID: 27015836 |
Ref: The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition. PMID: 28245089 |